The purpose of this study is to investigate if a novel brief intervention for Posttraumatic stress disorder (PTSD) is comparable to other traditional clinical interventions for symptom reduction.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The Clinician Administered PTSD Scale for DSM-5 (CAPS-5)
Timeframe: Data collection will take place baseline (T1), three weeks post treatment (T2) and at 6-month follow-up (T3).